Last reviewed · How we verify
NCT06226480: POD
Machine Learning Algorithm for Predicting Postoperative Delirium in Elderly Patients After Thoracic Surgery
trial in Postoperative Delirium in 3,967 participants. Completed in 31 July 2024.
20 July 2024
Quick facts
| Lead sponsor | Affiliated Hospital of Nantong University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,967 |
| Start date | 25 February 2024 |
| Primary completion | 20 July 2024 |
| Estimated completion | 31 July 2024 |
| Sites | 1 location across China |
Conditions studied
- Postoperative Delirium — all drugs for Postoperative Delirium →
Sponsor
Affiliated Hospital of Nantong University
Who can join
65 and older, any sex, with Postoperative Delirium. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Postoperative delirium (POD) is a common and severe complication in patients undergoing major surgery, especially in the elderly. POD has been proven to be associated with increased morbidity and mortality, institutionalization, and high healthcare costs. This retrospective cohort study aimed to use machine learning methods to develop clinically meaningful models to support clinical decision making.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06226480
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postoperative Delirium
Currently open trials in the same condition.
- NCT07323485 — Inflammatory Biomarkers and Postoperative Delirium in Pediatric Circumcision · recruiting
- NCT07411794 — Dexmedetomidine vs Midazolam in Coronary Artery By-pass Surgery · NA · recruiting
- NCT07239648 — Postoperative Delirium in Patients Undergoing Cardiac Surgery · recruiting
- NCT07217912 — Daridorexant to Prevent Post-cardiotomy Delirium · Phase 2 · recruiting
- NCT07108764 — Intraoperative Infusion of Either Lidocaine or Dexmedetomidine on Regional Cerebral Oxygen Saturation and Postoperative · NA · recruiting
Other Affiliated Hospital of Nantong University trials
Trials by the same sponsor.
- NCT07506668 — RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas · Phase 1, PHASE2 · not yet recruiting
- NCT07342283 — QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer · Phase 2 · recruiting
- NCT07382453 — Effect of PAE Hydrogel Loaded With tRF-ASO-Exo on Patients With Diabetic Ocular Surface Diseases · Phase 2 · not yet recruiting
- NCT07247838 — Prospective Cohort Control Study on Changes in Gut Microbiota in Ischemic Stroke · recruiting
- NCT07271147 — Effects of taVNS Combined With Dexmedetomidine on POVN · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06226480 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Affiliated Hospital of Nantong University
- Last refreshed: 3 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06226480.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing